SAMANTHA SMYTHE: Open Payments
NPI 1902466881 · LAKE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 33 payments from 10 companies in 2025. Trend: 2023 $600 · 2024 $677 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $215 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| ABBVIE INC. | 2 | $54 |
| Amgen Inc. | 3 | $48 |
| Vifor Pharma, Inc. | 1 | $30 |
| Exact Sciences Corporation | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| PFIZER INC. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Rybelsus, LEQVIO, Ozempic, Veltassa, OTEZLA, UBRELVY, Wegovy, QULIPTA.
Industry payments across FL — which companies pay providers there.
